| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/23/1996 | US5539082 Peptide nucleic acids |
| 07/23/1996 | US5539063 Polymer for making poly(ethylene glycol)-protein conjugates |
| 07/23/1996 | US5538952 Using human casein |
| 07/23/1996 | US5538949 Angiogenesis inhibitors |
| 07/23/1996 | US5538947 Growth inhibitory factor |
| 07/23/1996 | US5538946 Hirudin derivatives with delayed action |
| 07/23/1996 | US5538892 Nucleic acids encoding a TGF-β type 1 receptor |
| 07/23/1996 | US5538886 Anti-oncogene, transmembrane signalling |
| 07/23/1996 | US5538885 Expression systems |
| 07/23/1996 | US5538880 Method for preparing fertile transgenic corn plants |
| 07/23/1996 | US5538877 Method for preparing fertile transgenic corn plants |
| 07/23/1996 | US5538868 Recombinant ricin toxin fragments |
| 07/23/1996 | US5538866 Immunoassay; medical diagnosis |
| 07/23/1996 | US5538865 Antigens for viral hepatitis |
| 07/23/1996 | US5538863 Dna and genetic engineering with proteins |
| 07/23/1996 | US5538862 Heat-inducible N-degron module |
| 07/23/1996 | US5538861 DNA encoding a stimulating factor for the axl receptor |
| 07/23/1996 | US5538856 Screening kit and method for diagnosing chronic immune dysfunction syndrome |
| 07/23/1996 | US5538854 Method for the determination of predisposition to autoimmune disease |
| 07/23/1996 | US5538853 Antibody polypeptides for detection by binding and labels |
| 07/23/1996 | US5538851 Primers for the amplification of genes coding for the enterotoxin and the lecithinase of Clostridium perfringens and their application to the determination of the presence and numeration of these bacteriae |
| 07/23/1996 | US5538846 Diagnosis of leukemia, detecting translocation |
| 07/23/1996 | US5538845 Beta-amyloid peptide production inhibitors and methods for their identification |
| 07/23/1996 | US5538844 Transport protein gene from the Huntington's disease region |
| 07/23/1996 | US5538525 Biocidal proteins |
| 07/23/1996 | CA1338470C Dna clone of human thrombomodulin |
| 07/18/1996 | WO1996021742A1 Method for modulating processes mediated by farnesoid activated receptors |
| 07/18/1996 | WO1996021741A1 Nucleic acid probes for the detection and identification of fungi |
| 07/18/1996 | WO1996021740A1 Methods of determining endogenous thrombin potential (etp) and thrombin substrates for use in said methods |
| 07/18/1996 | WO1996021734A2 P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods |
| 07/18/1996 | WO1996021733A2 Transfert of dna in cells with the view to correcting the adrenoleucodystrophy |
| 07/18/1996 | WO1996021732A1 Il-2r-associated polypeptide and dna molecules coding therefor |
| 07/18/1996 | WO1996021728A2 Transgenic animals having a defective thyroid hormone receptor gene |
| 07/18/1996 | WO1996021727A1 Immunogenic compositions containing recombinant attenuated poxviruses expressing htlv antigens |
| 07/18/1996 | WO1996021726A1 Identification of a distinct retinoid-responsive pathway and uses therefor |
| 07/18/1996 | WO1996021677A1 Retinoid x receptor-interacting polypeptides and related molecules and methods |
| 07/18/1996 | WO1996021676A1 Growth factor analogs |
| 07/18/1996 | WO1996021675A2 Capturing of microorganisms using complement components |
| 07/18/1996 | WO1996021673A1 Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen |
| 07/18/1996 | WO1996021672A1 Immunotherapeutic agent derived from bacteria |
| 07/18/1996 | WO1996021671A1 Development of dna probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes |
| 07/18/1996 | WO1996021468A2 Chemically modified interferon |
| 07/18/1996 | WO1996021465A2 Immunogenic conjugate molecules |
| 07/18/1996 | WO1996021464A1 Compositions for the delivery of antigens |
| 07/18/1996 | WO1996021458A1 Collagen-based methods and formulations for the treatment of immune system-mediated diseases |
| 07/18/1996 | WO1996021457A1 Allosteric control of nuclear hormone receptors |
| 07/18/1996 | WO1996021416A2 Methods and compositions for treatment of solid tumors in vivo |
| 07/18/1996 | WO1996021356A1 Methods and compositions for inducing mucosal immune responses |
| 07/18/1996 | WO1996009399A3 Chimeric adenovirus for gene delivery |
| 07/18/1996 | WO1996009395A3 Drug for the prevention and treatment of auto-immune and viral diseases, and diagnostic agents for detecting said diseases |
| 07/18/1996 | WO1996009390A3 A novel fungal multisubunit protein complex critical for expression of fungal proteins |
| 07/18/1996 | WO1996008582A3 Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| 07/18/1996 | WO1996008569A3 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
| 07/18/1996 | WO1996006860A3 Gradual modification, super-agonists and antagonists of signal-proteins and peptides |
| 07/18/1996 | WO1996003122A3 Use of gabapentin in the treatment of anxiety and panic |
| 07/18/1996 | WO1995034669A3 Retroviral gene therapy vectors and therapeutic methods based thereon |
| 07/18/1996 | WO1995033062A3 Method for introducing foreign matter into higher eukaryotic cells |
| 07/18/1996 | DE4431945A1 Agent contg. interleukin=8 and/or its active fragments |
| 07/18/1996 | CA2210318A1 Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen |
| 07/18/1996 | CA2210248A1 Allosteric control of nuclear hormone receptors |
| 07/18/1996 | CA2210088A1 Collagen-based methods and formulations for the treatment of immune system-mediated diseases |
| 07/18/1996 | CA2209990A1 P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods |
| 07/18/1996 | CA2209941A1 Development of dna probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes |
| 07/18/1996 | CA2209557A1 Chemically modified interferon |
| 07/18/1996 | CA2209492A1 Compositions for the delivery of antigens |
| 07/18/1996 | CA2209247A1 Nucleic acid probes for the detection and identification of fungi |
| 07/18/1996 | CA2209064A1 Methods and compositions for inducing mucosal immune responses |
| 07/17/1996 | EP0721983A1 Methods of producing biologically active peptide dimers |
| 07/17/1996 | EP0721982A1 New staphylokinase derivatives |
| 07/17/1996 | EP0721981A1 Novel lipase, microorganism producing the lipase, process for producing the lipase, and use of the lipase |
| 07/17/1996 | EP0721958A2 Immunological assay for quantifying PEG-modified human granulocyte colony stimulating factor |
| 07/17/1996 | EP0721957A1 Compound ge3 |
| 07/17/1996 | EP0721782A2 Influenza vaccine containing pertussis toxin |
| 07/17/1996 | EP0721586A1 Methods and compositions for treatment of bcr-abl associated leukemias and other cell proliferative disorders |
| 07/17/1996 | EP0721510A1 Anti-cancer gene therapy by modulation of immune or inflammatory response |
| 07/17/1996 | EP0721509A1 Fertile, transgenic maize plants and methods for their production |
| 07/17/1996 | EP0721508A1 Receptor-activated reporter systems |
| 07/17/1996 | EP0721506A1 Bacterial exported proteins and acellular vaccines based thereon |
| 07/17/1996 | EP0721505A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 07/17/1996 | EP0721504A1 Immunoreactive peptide sequence from a 43 kd human cancer antigen |
| 07/17/1996 | EP0721501A1 Pharmaceutical composition comprising phosphatase or a derivative thereof |
| 07/17/1996 | EP0721470A1 Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer |
| 07/17/1996 | EP0721469A1 Anti-gp39 antibodies and uses therefor |
| 07/17/1996 | EP0721468A1 Novel peptide, active as inhibitors of platelet aggregation |
| 07/17/1996 | EP0721467A1 Use of relaxin as an analgesic and palliative for intractable pain |
| 07/17/1996 | EP0721466A1 Protective antigens against parasites |
| 07/17/1996 | EP0721464A1 Neuron regulatory factor for promoting neuron survival |
| 07/17/1996 | EP0721463A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
| 07/17/1996 | EP0721352A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 07/17/1996 | EP0721351A1 Haplotype-matched cytokine-secreting cells and methods of using to stimulate an immune response |
| 07/17/1996 | EP0721346A1 Methods for inducing antigen-specific t cell tolerance |
| 07/17/1996 | EP0721345A1 Prostatic cancer vaccine |
| 07/17/1996 | EP0721342A1 The semaphorin gene family |
| 07/17/1996 | EP0721341A1 Cloning and characterization of the complete mage-1 gene |
| 07/17/1996 | EP0721340A1 Use of cell surface receptor targeted molecules for the treatment of viral diseases |
| 07/17/1996 | EP0697906A4 Artificial receptors, antibodies, and enzymes |
| 07/17/1996 | EP0681427A4 Tomato spotted wilt virus. |
| 07/17/1996 | EP0593450B1 COMPOSITIONS comprising omega conotoxin peptide derivatives and their use FOR TREATING ISCHEMIA-RELATED NEURONAL DAMAGE |
| 07/17/1996 | EP0506868B1 Immunologically active proteines from borrelia burgdorferi, related test kits and vaccine |
| 07/17/1996 | EP0496866B1 Hemoglobin-oligomer based composition and method to make same |